title: The study and treatment of the myelodysplastic patient.
authors.forename: M A
authors.initials: MA
authors.lastname: Sanz
authors.forename: J M
authors.initials: JM
authors.lastname: Bennett
authors.forename: T
authors.initials: T
authors.lastname: Vallespí
authors.forename: D
authors.initials: D
authors.lastname: Hoelzer
mesh_terms: D001853:Bone Marrow / Q000473:pathology; D002869:Chromosome Aberrations; D002986:Clinical Trials as Topic; D002999:Clone Cells / Q000473:pathology; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D009190:Myelodysplastic Syndromes / Q000145:classification / Q000235:genetics / Q000401:mortality / Q000473:pathology / Q000628:therapy; D009857:Oncogenes; D011379:Prognosis; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D016298:Hematopoietic Cell Growth Factors; D007155:Immunologic Factors; D011994:Recombinant Proteins